MLB: White Sox sign RHP Mike Clevinger to one-year deal

Date:

Share post:


Right-hander Mike Clevinger agreed to terms with the Chicago White Sox on a one-year, $12 million contract Sunday.

Per the White Sox, Clevinger will receive $8 million in 2023 with a mutual $12 million option for 2024 that includes a $4 million buyout.

Clevinger, who turns 32 later this month, went 7-7 with a 4.33 ERA in 23 appearances (22 starts) for the San Diego Padres last season.

The former fourth-round draft pick by the Los Angeles Angels in 2011 spent his first 4 1/2 seasons in Cleveland before his young career hit a snag. He was moved to the Padres at the 2020 trade deadline after he had been suspended for violating team COVID-19 protocol.

Clevinger then pitched just four games with the Padres in 2020 before he needed Tommy John surgery, forcing him to miss the entire 2021 campaign.

In 128 career appearances (114 starts), Clevinger has gone 51-30 with a 3.39 ERA and 694 strikeouts over 656 2/3 innings.

The White Sox were projected to be a World Series contender last season but missed the playoffs with an 81-81 record. Manager Tony La Russa left the team for health considerations on Aug. 31 and did not return. Pedro Grifol was hired as manager on Nov. 1.

–Field Level Media

spot_img

Related articles

MLB: Mariners trade for Cubs INF/OF Miles Mastrobuoni

The Seattle Mariners acquired utility player Miles Mastrobuoni from the Chicago Cubs on Tuesday for cash considerations. In a...

MLB: Police: Former Orioles P Brian Matusz likely died from overdose

The cause of death of former Baltimore Orioles pitcher Brian Matusz likely is a drug overdose, The Baltimore...

MLB: Reports: Japanese RHP Roki Sasaki rules out Yanks, Mets

Roki Sasaki's window to sign with a major league team opens Wednesday, but the coveted Japanese right-hander has...

MLB: Mariners sign INF Donovan Solano to one-year deal

The Seattle Mariners signed veteran infielder Donovan Solano to a one-year contract on Monday. According to a published report,...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.